| Announce Date | 08/06/2025 | 
| EPS Normalized Actual | $-1.33 (Miss by $-0.24) | 
| EPS GAAP Actual | $-1.33 (Miss by $-0.24) | 
| Revenue Actual | $0B | 
| Revenue Surprise | Beat by $0M | 
| Announce Date | 12/30/2025 (Pre-Market) | 
| EPS Normalized Estimate | $-1.57 | 
| EPS GAAP Estimate | $-1.57 | 
| Revenue Estimate | $0.0112B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Dec 2029 | -7.775 | -4.01 | -9.41579 | -6.40203 | 1 | 
| Dec 2028 | -18.04 | -1.73 | -18.04 | -18.04 | 0 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -1.33 | 0.32 | 0B | -INF% | -10.1M | 
| FQ1 2025 (Mar 2025) | -1.17 | 0.57 | 0B | -INF% | -9.6M | 
| FQ4 2024 (Dec 2024) | 0 | 2.58 | 0.007357B | 2.64% | 1.22M | 
| FQ3 2024 (Sep 2024) | -0.0015 | 2.2285 | 0.006845B | 100% | 0.89M | 
| FQ2 2024 (Jun 2024) | -1.98 | -3.32259 | 0.008533B | 100% | 8.53M | 
| FQ1 2024 (Mar 2024) | -1.66 | -1.66 | 0.005785B | 100% | 5.79M | 
| FQ4 2023 (Dec 2023) | -2 | -2 | 0.007163B | 100% | 7.16M | 
| FQ3 2023 (Sep 2023) | -0.0003 | -0.0003 | 0B | NAN% | 0M | 
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
-1.57
Consensus Revenue Estimates
0.0112B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | -1.3386 | -- | -1.41426 | -1.26294 | 1 | 
| FQ1 2027 (Mar 2027) | 1.6692 | -- | 1.57485 | 1.76355 | 1 | 
| FQ4 2026 (Dec 2026) | -2.82 | -- | -2.82 | -2.82 | 0 | 
| FQ3 2026 (Sep 2026) | -2.77 | -- | -2.77 | -2.77 | 0 | 
| FQ2 2026 (Jun 2026) | -2.33 | 42.92 | -2.33 | -2.33 | 0 | 
| FQ1 2026 (Mar 2026) | -1.82 | 35.71 | -1.82 | -1.82 | 0 | 
| FQ4 2025 (Dec 2025) | -1.57 | -- | -1.57 | -1.57 | 0 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 0.05B | -- | 0.05B | 0.05B | 1 | 
| FQ1 2027 (Mar 2027) | 0.12B | -- | 0.11B | 0.12B | 1 | 
| FQ4 2026 (Dec 2026) | 0B | -- | 0B | 0B | 0 | 
| FQ3 2026 (Sep 2026) | 0B | -- | 0B | 0B | 0 | 
| FQ2 2026 (Jun 2026) | 0B | -- | 0B | 0B | 0 | 
| FQ1 2026 (Mar 2026) | 0.01B | -- | 0.01B | 0.01B | 0 | 
| FQ4 2025 (Dec 2025) | 0.01B | 34.31 | 0.01B | 0.01B | 0 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
2
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -1.65 | -1.33 | 0.32 | -24.06% | 
| FQ1 2025 (Mar 2025) | -1.74 | -1.17 | 0.57 | -48.72% | 
| FQ4 2024 (Dec 2024) | -2.58 | 0 | 2.58 | INF% | 
| FQ3 2024 (Sep 2024) | -2.23 | -0.0015 | 2.2285 | -148566.67% | 
| FQ2 2024 (Jun 2024) | 1.34259 | -1.98 | -3.32259 | 167.81% | 
| FQ1 2024 (Mar 2024) | -1.66 | -1.66 | 100% | |
| FQ4 2023 (Dec 2023) | -2 | -2 | 100% | |
| FQ3 2023 (Sep 2023) | -0.0003 | -0.0003 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0.01B | $0B | $-10.1M | -INF% | 
| FQ1 2025 (Mar 2025) | $0.01B | $0B | $-9.6M | -INF% | 
| FQ4 2024 (Dec 2024) | $0.01B | $0.01B | $1.22M | 16.58% | 
| FQ3 2024 (Sep 2024) | $0.01B | $0.01B | $0.89M | 12.94% | 
| FQ2 2024 (Jun 2024) | $0B | $0.01B | $8.53M | 100% | 
| FQ1 2024 (Mar 2024) | $0B | $0.01B | $5.79M | 100% | 
| FQ4 2023 (Dec 2023) | $0B | $0.01B | $7.16M | 100% | 
| FQ3 2023 (Sep 2023) | $0B | $0B | $0M | NAN% |